{
  "id": "mhgap#risk_safety_26d4f56f",
  "content": "PSY8. In adults with bipolar disorders in remission, are mood\nstabilizers and antipsychotics effective and safe?\nRecommendation (update): 8.1 Mood stabilizers (namely carbamazepine, lithium, valproic acid [sodium\nvalproate]) or oral antipsychotic medicines (namely aripiprazole, olanzapine,\nquetiapine) should be considered for maintenance treatment for adults with\nbipolar disorder in remission, carefully balancing effectiveness, side-effects\nand individual preference.\nStrength of recommendation: Conditional\nCertainty of evidence: Low\n8.2 Valproic acid (sodium valproate) should not be used in women and girls\nof childbearing potential with bipolar disorder in remission owing to the high\nrisk of birth defects and neurodevelopmental disorders in babies in utero.\nStrength of recommendation: Strong\nCertainty of evidence: Low\nJustification – Aripiprazole plus sodium valproate ranked first,\ny Data were extracted from an NMA: Kishi et al., lamotrigine plus sodium valproate ranked second\n2021 (41 RCTs on the use of mood stabilizers and quetiapine ranked third.\nand/or antipsychotics for bipolar disorder in the – The certainty of the evidence was very low to low.\nmaintenance phase) (196). y Recurrence/relapse of manic/hypomanic/ mixed\ny Recurrence/relapse rate of any mood episode: episodes:\n– For this outcome, almost all medicines – For this outcome all medicines outperformed",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety PSY8. In adults with bipolar disorders in remission, are mood\nstabilizers and antipsychotics effective and safe?\nRecommendation (update): 8.1 Mood stabilizers (namely carbamazepine, lithium, valproic acid [sodium\nvalproate]) or oral antipsychotic medicines (namely aripiprazole, olanzapine,\nquetiapine) should be considered for maintenance treatment for adults with\nbipolar disorder in remission, carefully balancing effectiveness, side-effects\nand individual preference.\nStrength of recommendation: Conditional\nCertainty of evidence: Low\n8.2 Valproic acid (sodium valproate) should not be used in women and girls\nof childbearing potential with bipolar disorder in remission owing to the high\nrisk of birth defects and neurodevelopmental disorders in babies in utero.\nStrength of recommendation: Strong\nCertainty of evidence: Low\nJustification – Aripiprazole plus sodium valproate ranked first,\ny Data were extracted from an NMA: Kishi et al., lamotrigine plus sodium valproate ranked second\n2021 (41 RCTs on the use of mood stabilizers and quetiapine ranked third.\nand/or antipsychotics for bipolar disorder in the – The certainty of the evidence was very low to low.\nmaintenance phase) (196). y Recurrence/relapse of manic/hypomanic/ mixed\ny Recurrence/relapse rate of any mood episode: episodes:\n– For this outcome, almost all medicines – For this outcome all medicines outperformed Psy8. in adults with bipolar disorders in remission, are mood\nstabilizers and antipsychotics effective and safe?"
}